RENEOS 0.5mg tablets medication leaflet

A10BX02 repaglinide • Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Other blood glucose lowering drugs, excl. insulins

Repaglinide is a medication used to control blood sugar levels in patients with type 2 diabetes. It stimulates the pancreas to release insulin, thereby helping to lower blood sugar levels after meals.

The medication is taken orally, usually before meals, and should be used as directed by your doctor. It is important to follow the recommended diet and exercise regimen to achieve the best results.

Side effects may include hypoglycemia (low blood sugar), nausea, diarrhea, or weight gain. In rare cases, severe allergic reactions or other complications may occur, requiring immediate medical attention.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as liver or kidney diseases, to ensure the safe use of repaglinide.

General data about RENEOS 0.5mg

Substance: repaglinide

Date of last drug list: 01-06-2025

Commercial code: W56718002

Concentration: 0.5mg

Pharmaceutical form: tablets

Quantity: 90

Product type: generic

Price: 35.18 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: DELORBIS PHARMACEUTICALS LTD. - CIPRU

Holder: ZENTIVA, K.S. - REPUBLICA CEHA

Number: 8505/2016/02

Shelf life: 3 years

Pharmaceutical forms available for repaglinide

Concentrations available for repaglinide

0.5mg, 1mg, 2mg, 4mg

Other substances similar to repaglinide

Compensation lists for RENEOS 0.5mg ZENTIVA

NHP 5 (C2) - Diabetes

Price

Copayment

Patient

35.18 RON

16.87 RON

18.31 RON